Remote Patient Management in Peritoneal Dialysis. Группа авторов
remarkable expansion of automated PD has been mostly related to the technological improvement of modern cyclers that today are safe, compact, portable, and easy to use. With the parallel improvement of the dedicated software, the spectrum of PD techniques has been expanded leading to a personalized prescription case by case depending on the peritoneal membrane characteristics and results obtained from kinetic models and simulations. The combination of all these elements makes possible today to make a true RPM. Further advances and developments can be expected for the future. Hardware can be further miniaturized, possibly leading to wearable solutions. New biosensors will be developed to enable a fully integrated remote machine and patient monitoring providing information on intraperitoneal pressure and operating a feedback on inflow and drainage kinetics. This will not only optimize exchange volumes and solute and water transport, but will also avoid short- and long-term complications. Moreover, biosensor could also be used to provide a turbidimetric measure of the effluent, avoiding unwanted delays in the diagnosis of peritonitis.
Software-guided prescription based on collected information will allow the cycler to optimize delivery of different PD modalities. Profiling the fill volume, glucose concentration, and dwell time will have a favorable effect on UF and solute transport in every single cycle [14].
Lastly, RPM could include more aspects of treatment, not just limited to the dialysis technique. Data on blood pressure and patient’s weight will be recorded together with other information, possibly captured by imaging or video conferences [15]. All these efforts will be directed to make PD a true home-based therapy with minimum requirement of hospital visits or admission.
References
1Jain AK, Blake P, Cordy P, Garg AX: Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 2012; 23: 533–544.
2Marinangeli G, Cabiddu G, Neri L, Viglino G, Corciulo R, Rocca AR, Laudon A, Finato V: [Peritoneal Dialysis in Italy: the fourth GSDP-SIN census 2012]. G Ital Nefrol 2017; 34: 110–137.
3Boen ST, Mulinari AS, Dillard DH, Scribner BH: Periodic peritoneal dialysis in the management of chronic uremia. Trans Am Soc Artif Intern Organs 1962;8:256–265.
4Boen ST, Mion CM, Curtis FK, Shilipetar G: Periodic peritoneal dialysis using the repeated puncture technique and an automatic cycling machine. Trans Am Soc Artif Intern Organs 1964; 10:409–414.
5Diaz-Buxo JA: The place for automated peritoneal dialysis. Adv Perit Dial 1992; 8: 98–101.
6Dell’Aquila R, Rodighiero MP, Spano E, Di Loreto P, Kohn CO, Cruz D, Polanco N, Kuang D, Corradi V, De Cal M, Ronco C: Advances in the technology of automated, tidal, and continuous flow peritoneal dialysis. Perit Dial Int 2007; 27(suppl 2):S130–S137.
7Corciulo R, Russo R: [Cyclers for APD: current potential and possible developments]. G Ital Nefrol 2009; 26: 355–368.
8Ronco C, Amerling R: Continuous flow peritoneal dialysis: current state-of-the-art and obstacles to further development. Contrib Nephrol 2006; 150: 310–320.
9Ronco C, Fecondini L: The vicenza wearable artificial kidney for peritoneal dialysis (ViWAK PD). Blood Purif 2007; 25: 383–388.
10Rosner MH, Ronco C: Remote monitoring for continuous peritoneal dialysis. Contrib Nephrol 2012; 178: 68–73.
11Rosner MH, Ronco C: Remote monitoring for the wearable artificial kidney. Contrib Nephrol 2011; 171: 243–247.
12Milan Manani S, Crepaldi C, Giuliani A, Virzi GM, Garzotto F, Riello C, de Cal M, Rosner MH, Ronco C: Remote monitoring of automated peritoneal dialysis improves personalization of dialytic prescription and patient’s independence. Blood Purif 2018; 46: 111–117.
13Milan Manani S, et al: Longitudinal experience with remote monitoring for automated peritoneal dialysis patients. Nephron 2019; 1–9.
14Fischbach M, Zaloszyc A, Schaefer B, Schmitt C: Adapted automated peritoneal dialysis. Adv Perit Dial 2014; 30: 94–97.
15Nayak KS, Ronco C, Karopadi AN, Rosner MH: Telemedicine and remote monitoring: supporting the patient on peritoneal dialysis. Perit Dial Int 2016; 36: 362–366.
Claudio Ronco
Department of Nephrology, Dialysis and Transplantation
San Bortolo Hospital, Viale Rodolfi 37
IT–36100 Vicenza (Italy)
E-Mail [email protected]
Information Communication Technology and Remote Monitoring
Ronco C, Crepaldi C, Rosner MH (eds): Remote Patient Management in Peritoneal Dialysis.
Contrib Nephrol. Basel, Karger, 2019, vol 197, pp 17–27 (DOI: 10.1159/000496314)
______________________
Two-Way Patient Monitoring in PD: Technical Description of Sharesource
Andrew T. Gebhardt · Arvind Mishra
Baxter Healthcare Corporation, Deerfield, Illinois, USA
______________________
Abstract
The SHARESOURCE platform was designed to transform how clinicians approach dialysis by empowering them to focus on improving clinical decision making for their patients. Sharesource supports remote patient management through secure communication with Baxter’s AMIA, HOMECHOICE CLARIA and KAGUYA peritoneal dialysis cyclers. Sharesource organizes and presents the treatment data to the clinician in a timely manner for assessment, allowing the clinician to review the treatment results, assess the therapy, and evaluate patient status and compliance. If the clinician determines that a change to the patient’s therapy is required, Sharesource provides the clinician the ability to act on that assessment by updating the patient’s device settings that can be communicated to the cycler in time for the patient’s next treatment.
© 2019 S. Karger AG, Basel
Overview
The SHARESOURCE Medical Device Connectivity platform is a cloud-based global family of products that includes a medical device connectivity platform, a peritoneal dialysis (PD) adequacy calculator, and support for the ordering of PD therapy supplies. Sharesource is partitioned into 4 regions to support multiple products, languages, and geographies:
•Europe,